Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joseph Wender Insider Profile
11 Followers
Joseph Wender, Director at Ionis Pharmaceuticals, holds 59.36K shares in Outfront Media (Ticker: OUT), holds 128.08K shares in Ionis Pharmaceuticals (Ticker: IONS).
Profitable Transactions
6 out of 9 Profitable Transactions
Average Return
+20.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Joseph Wender holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 20, 2015 - Mar 20, 2016
Return:+47.40%
The most profitable trade made by Joseph Wender
Joseph Wender's Trading History
Ionis Pharmaceuticals
May 13, 2024
Director
Uninformative Buy
568.48K
$6.03M
Outfront Media
Jun 10, 2024
Director
Uninformative Buy
149.13K
$835.73K
List of latest transactions for each holding click on a transaction to see Joseph Wender's performance on stock
You May Also Like
Joseph Wender insider profile FAQ
What is the percentage of profitable transactions made by Joseph Wender?
The percentage of profitable transactions made by Joseph Wender is 67%.
What is the average return per transaction made by Joseph Wender?
The average return per transaction made by Joseph Wender is 20.40%.
What stocks does Joseph Wender hold?
Joseph Wender holds: IONS, OUT stocks.
What was Joseph Wender’s latest transaction?
Joseph Wender latest transaction was an Uninformative Buy of $149.13K.
What was Joseph Wender's most profitable transaction?
Joseph Wender’s most profitable transaction was an Informative Sell of IONS stock on March 20, 2015. The return on the trade was 47.40%.
What is Joseph Wender's role in Ionis Pharmaceuticals?
Joseph Wender's role in Ionis Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.